Novo Nordisk | Fremdkapital

Loan Capital Veränderung Datum
ANI Pharmaceuticals USD 284.61M 212K 2024-03
Aurora Cannabis CAD 78.36M 1.6M 2023-12
Bausch Health Companies USD 21.54B 402M 2024-03
Bristol-Myers Squibb USD 49.49B 17.35B 2024-03
Canopy Growth CAD 493.29M 94.62M 2024-03
Catalent USD 4.93B 26M 2024-03
Corcept Therapeutics USD 0 0 2022-06
Drreddys Laboratories INR 6.15B 109M 2023-12
Eli Lilly USD 24.56B 6.64B 2024-03
GlaxoSmithKline GBP 15.2B 788M 2023-12
Merck USD 31.14B 2.83B 2024-03
Novartis USD 17.19B 2.84B 2024-03
Novo Nordisk DKK 16.76B 3.76B 2024-03
Pacira USD 511.69M 2.11M 2024-03
Perrigo USD 3.62B 7.9M 2024-03
Prestige Brands USD 1.13B 73.73M 2024-03
Supernus Pharmaceuticals USD 0 400.38M 2022-06
Zoetis USD 6.56B 2M 2024-03



Novo Nordisk Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2024.